Enfamil recently launched a new product, the NeuroPro infant formula, which is said to represent its "next generation of formula."
Enfamil NeuroPro is the first-ever formula of its kind in the United States with Milk Fat Globule Membrane (MFGM), which has been clinically shown to help close the gap in cognitive development between formula-fed and breastfed infants. The new formula is said to use the composition and functional benefits of breast milk to support infant nutrition and brain-building early in life.
The easy-to-digest Enfamil NeuroPro formula for infants between zero to 12 months of age also includes probiotics for immune health, as well as DHA, which is an inclusion that set Enfamil apart as an innovator in the infant formula market more than a decade ago.
Brain-Building Infant Formulas
Enfamil's NeuroPro Infant Formula Supports Cognitive Development
Trend Themes
1. Brain-building Infant Formulas - The launch of Enfamil's NeuroPro infant formula with MFGM presents an opportunity for other infant formula brands to develop brain-boosting formulas.
2. Closing the Cognitive Development Gap - Enfamil's NeuroPro formula, which helps close the cognitive development gap between formula-fed and breastfed infants, opens up opportunities for companies to develop products that bridge this gap.
3. Functional Benefits of Breast Milk - The use of breast milk composition and functional benefits in Enfamil NeuroPro formula showcases a potential area for innovation in the infant formula market.
Industry Implications
1. Infant Formula - The launch of Enfamil's NeuroPro formula highlights the potential for innovation in the infant formula industry, particularly in the development of brain-boosting formulas for infants.
2. Baby Food - The inclusion of clinically proven cognitive development benefits in infant formula opens opportunities for the baby food industry to create brain-boosting products for infants.
3. Nutritional Supplements - The incorporation of probiotics and DHA in Enfamil NeuroPro formula suggests a disruptive innovation opportunity in the nutritional supplements industry, specifically for infant health and development.